Scandinavian ChemoTech AB (publ) strengthening its position despite ongoing pandemic - Q4 report 2020
Year-End Report January – December 2020 EXECUTIVE SUMMARY Fourth quarter · Net sales amounted to kSEK 0 (72) · Profit before tax amounted to kSEK -2 792 (-4 663) · Earnings per share amounted to SEK -0,46 SEK (-1,37) · Cash flow from operating activities totalled to kSEK -2 794 (-3 159) · The Order book amounted to kSEK 422 at the end of the fourth quarter Period 1 January - 31 December · Net sales amounted to kSEK 131 (484) · Profit before tax amounted to kSEK -8 872 (-7 655 · Earnings per share amounted to SEK -1,95 (-2,35) · Cash flow from